Grupo de Investigacao do Cancro Digestivo
1 clinical trials · Sponsor
◉ Watch Grupo de Investigacao do Cancro Digestivo
| Record | Firm | Date |
|---|---|---|
| XELOX Plus Cetuximab as First-Line Therapy in Patients With Metastatic Colorectal Cancer (NCT00215722) | Grupo de Investigacao do Cancro Digestivo | 2005-07-01 |
Track Grupo de Investigacao do Cancro Digestivo automatically
Every clearance here is in the API, with alerts when new ones post.